These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16757435)

  • 1. Recurrent extramedullary relapse of acute promyelocytic leukemia after allogeneic stem cell transplantation: successful treatment by arsenic trioxide in combination with local radiotherapy.
    Kai T; Kimura H; Shiga Y; Ogawa K; Sato H; Maruyama Y
    Int J Hematol; 2006 May; 83(4):337-40. PubMed ID: 16757435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment concepts of acute promyelocytic leukemia.
    Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.
    Lou Y; Suo S; Tong H; Ye X; Wang Y; Chen Z; Qian W; Meng H; Mai W; Huang J; Tong Y; Jin J
    Leuk Res; 2013 Nov; 37(11):1451-6. PubMed ID: 23958062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation.
    Tedeschi A; Cairoli R; Marenco P; Nosari A; Tresoldi E; Di Bona E; Montillo M; Morra E
    Leukemia; 2002 Dec; 16(12):2455-6. PubMed ID: 12454753
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term remission of extramedullary relapse from acute promyelocytic leukemia after treatment with arsenic trioxide, intrathecal chemotherapy, and brain irradiation.
    Farhat M; Venugopal P
    Clin Adv Hematol Oncol; 2007 Apr; 5(4):320-3; discussion 323-4. PubMed ID: 17607291
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.
    Gao N; Wang XX; Sun JR; Yu WZ; Li XZ
    Ann Hematol; 2017 May; 96(5):711-718. PubMed ID: 28238096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantation.
    Leoni F; Gianfaldoni G; Annunziata M; Fanci R; Ciolli S; Nozzoli C; Ferrara F
    Haematologica; 2002 May; 87(5):485-9. PubMed ID: 12010661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide.
    Sanford D; Lo-Coco F; Sanz MA; Di Bona E; Coutre S; Altman JK; Wetzler M; Allen SL; Ravandi F; Kantarjian H; Cortes JE
    Br J Haematol; 2015 Nov; 171(4):471-7. PubMed ID: 26205361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era.
    Ramadan SM; Di Veroli A; Camboni A; Breccia M; Iori AP; Aversa F; Cupelli L; Papayannidis C; Bacigalupo A; Arcese W; Lo-Coco F
    Haematologica; 2012 Nov; 97(11):1731-5. PubMed ID: 22689684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful bone marrow transplantation with a matched unrelated donor in an acute promyelocytic leukemia patient after reinduction therapy with arsenic trioxide].
    Iguchi T; Yokoyama K; Miyamoto K; Aisa Y; Shimizu T; Mori T; Ikeda Y; Okamoto S
    Rinsho Ketsueki; 2004 Jan; 45(1):75-7. PubMed ID: 14999939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
    Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases.
    Liso V; Specchia G; Pogliani EM; Palumbo G; Mininni D; Rossi V; Teruzzi E; Mestice A; Coppi MR; Biondi A
    Cancer; 1998 Oct; 83(8):1522-8. PubMed ID: 9781945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
    Shepshelovich D; Oniashvili N; Parnes D; Klein A; Muchtar E; Yeshaya J; Aviram A; Rabizadeh E; Raanani P
    Cancer Genet; 2015 Nov; 208(11):575-9. PubMed ID: 26471811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHA-Induced Peripheral Blood Cytogenetics and Molecular Analysis: a Valid Diagnostic and Follow-up Modality for Acute Promyelocytic Leukemia Patients Treated with ATRA and/or Arsenic Tri-oxide.
    Baba SM; Azad NA; Shah ZA; Afroze D; Pandith AA; Jan A; Aziz SA; Dar FA
    Asian Pac J Cancer Prev; 2016; 17(4):1999-2006. PubMed ID: 27221887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia.
    Westervelt P; Pollock JL; Oldfather KM; Walter MJ; Ma MK; Williams A; DiPersio JF; Ley TJ
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9468-73. PubMed ID: 12077315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute promyelocytic leukemia with Flt3-TKD and WT1 mutations relapsing in a testicle and followed by systemic relapse.
    Zou XL; Zeng K; Xie LP; Wang L; Chen M; Liu T; Niu T
    Acta Haematol; 2013; 130(4):223-9. PubMed ID: 23816818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation.
    Grigg A; Kimber R; Szer J
    Leukemia; 2003 Sep; 17(9):1916-7; author reply 1918. PubMed ID: 12970801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.